US Patent Issued to Supernus Pharmaceuticals on Sept. 29 for "Derivatives of substituted morpholines and uses thereof" (Maryland Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,218, issued on Sept. 29, was assigned to Supernus Pharmaceuticals Inc. (Rockville, Md.).

"Derivatives of substituted morpholines and uses thereof" was invented by Janak Khimchand Padia (Germantown, Md.) and Chungping Yu (Gaithersburg, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound of Formula I includes a stereoisomer thereof and/or a salt thereof; wherein R1 is a substituted alkane group, a heterocylic group, or a pyridine group; X is hydrogen, a halogen, an amino acid residue, a substituted amino acid residue, an alkyl group, or an ester. Such compounds may be used in pharmaceutical compositions and for the treatment of central nerv...